FDA 21 CFR Part 11: Electronic Records and Signatures Guide

21 CFR Part 11 is the FDA regulation that defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. For pharmaceutical companies, medical device manufacturers, biotechnology firms, and clinical research organizations, Part 11 compliance is essential for any system that creates, modifies, maintains, archives, retrieves, or transmits regulated records.

What Part 11 Covers

The regulation establishes two sets of requirements. For electronic records, systems must include validated functionality, the ability to generate accurate and complete copies, protection of records throughout their retention period, limited system access to authorized individuals, secure computer-generated audit trails, and operational system checks.

For electronic signatures, Part 11 requires that signatures be unique to one individual, verified before use, and administered with appropriate certification to the FDA. Biometric-based signatures must be designed to prevent reuse. Non-biometric signatures require at least two distinct identification components (such as user ID and password).

Who Needs Part 11 Compliance

Part 11 applies to any organization that maintains electronic records required by FDA regulations or uses electronic signatures in lieu of traditional handwritten signatures for FDA-regulated activities. This spans pharmaceutical manufacturing, clinical trials, medical device production, laboratory testing, and any FDA-regulated quality management system. SaaS vendors providing systems to these industries must ensure their platforms support Part 11 compliance.

Implementation Approach

Inventory all systems that create or manage FDA-regulated records. Conduct a Part 11 gap assessment for each system. Implement compliant audit trails, access controls, and electronic signature capabilities. Validate each system according to GAMP 5 or equivalent methodology. Develop SOPs for electronic record management and signature use. Maintain validation documentation for FDA inspection readiness.

Cost Considerations

System validation is typically the largest cost driver, ranging from $50,000 to $100,000 per system. Organizations with multiple regulated systems face cumulative costs of $200,000 to $500,000 or more. Cloud-based solutions have reduced infrastructure costs but still require validation. Ongoing costs include change control, periodic review, and revalidation after significant system changes.